Wellness Education
Lean Body
GLP-1, GIP, and glucagon receptor agonists represent the most significant advance in metabolic medicine. These peptides work by mimicking natural gut hormones to regulate appetite, blood sugar, and fat metabolism.
22%
Average body weight reduction with Tirzepatide
24%
Greater weight loss vs. single-agent therapies
~40%
Reduction in hunger signaling via hypothalamic pathways
How They Work
These peptides bind to receptors in the gut, brain, and pancreas to reduce hunger signals, slow gastric emptying, stimulate insulin release, and promote fat breakdown. Triple agonists like Retatrutide additionally activate glucagon receptors to further increase daily caloric burn and support lean mass preservation.
Key Benefits
Appetite Control
Reduces hunger signals by up to 40% through hypothalamic pathways
Fat Loss
Clinical trials show 15-22% total body weight reduction
Blood Sugar
Improves insulin sensitivity and fasting glucose
Cardiovascular
Emerging data shows reduction in heart attacks and stroke risk
Lean Body Category
2 compounds in this category
Browse all compounds →Educational Content. Category content is for informational purposes only. Not intended as medical advice, diagnosis, or treatment.
Compounds in Lean Body
2 compoundsTirzepatide
Dual GIP/GLP-1 Agonist
- Superior to single-agent therapies in every trial
- Activates two incretin pathways for broader metabolic impact
Reference Codes
[NV-2010]20mg[NV-2040]40mgRetatrutide
Triple GLP-1/GIP/Glucagon Agonist
- Broadest receptor pathway activation — 3 mechanisms at once
- Enhances daily energy expenditure and lean mass preservation
Reference Codes
[NV-3020]20mg[NV-3030]30mgAll compound profiles are for educational reference only. This content does not constitute medical advice, diagnosis, or treatment recommendations. Consult a qualified healthcare provider.